Forgot your password?
typodupeerror

+ - Michael J. Fox Donates $2M USD to a Finnish Medicine Company

Submitted by jones_supa
jones_supa (887896) writes "Biotie Therapies from Turku, Finland has signed a USD 2 million research contract with The Michael J. Fox Foundation (MJFF) to investigate SYN120 in Parkinson's disease patients with dementia. SYN120 is a dual antagonist of 5-HT6 and 5-HT2a receptors and these two distinct modes of action could result in a unique therapeutic profile for SYN120 combining pro-cognitive and antipsychotic activities. MJFF will fund an 80 patient, Phase 2a, randomized, double-blind, placebo-controlled trial of 16 weeks duration in patients with Parkinson's disease dementia. In addition to assessing safety and tolerability, the main focus of the trial will be to establish efficacy of SYN120 on cognition using the Cognitive Drug Research (CDR) Computerized Cognition Battery as the primary efficacy endpoint. This trial, which is expected to begin in H2 2014, will be conducted by the Parkinson Study Group (PSG) at approximately 10 US sites specializing in cognitive dysfunction in Parkinson's disease."
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Michael J. Fox Donates $2M USD to a Finnish Medicine Company

Comments Filter:

"Though a program be but three lines long, someday it will have to be maintained." -- The Tao of Programming

Working...